Trial Profile
A Multicenter, Randomized, Open-label, Investigator Initiated Trial of Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Progesterone (Primary) ; Hydroxyprogesterone
- Indications Preterm birth
- Focus Therapeutic Use
- Acronyms VICTORIA
- 14 Jun 2020 Status changed to completed, according to results published in the BJOG: An International Journal of Obstetrics and Gynaecology
- 14 Jun 2020 Primary endpoint (Preterm Birth Rate before 37 weeks of gestation) has not been met, according to results published in the BJOG: An International Journal of Obstetrics and Gynaecology
- 14 Jun 2020 Results published in the BJOG: An International Journal of Obstetrics and Gynaecology